other:Article Title: Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model
Article Snippet: Stock or Other Ownership: Armune Bioscience, Parallel6 Consulting or Advisory Role: Astellas Pharma, Medivation, Janssen Biotech, Dendreon, MDxHealth, Sanofi, Bayer, GenomeDx Biosciences, Armune Bioscience, Parallel6 Research Funding: Dendreon (Inst), Bayer (Inst), Amgen (Inst), Janssen Biotech (Inst), Myriad Genetics (Inst), GenomeDx Biosciences (Inst), Mitomics (Inst), Metabolon (Inst), POM Wonderful (Inst), Progenika (Inst) Travel, Accommodations, Expenses: Sanofi, Myriad Genetics, GenomeDx Biosciences
Article Title: Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Article Snippet: Honoraria: Takeda Pharmaceuticals Consulting or Advisory Role: Myriad Genetics, Janssen, Astellas Pharma, Dendreon Research Funding: Myriad Pharmaceuticals (Inst), Genomic Health (Inst), GenomeDx (Inst) Scott C. Morgan Honoraria: Bayer Consulting or Advisory Role: Janssen, Accuray, Bayer, AbbVie, Astellas Pharma, Ferring Pharmaceuticals, Sanofi
Article Title: 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort
Article Snippet: Daniel W. Lin Consulting or Advisory Role: Astellas Pharma, Clovis Oncology, Dendreon Research Funding: Genomic Health (Inst), GenomeDx (Inst), MDxHealth (Inst), Magforce Yingye Zheng Research Funding: Genomic Health (Inst) Ruixiao Lu Employment: Genomic Health, Exact Sciences Stock and Other Ownership Interests: Genomic Health, Exact Sciences Consulting or Advisory Role: Mission Bio Patents, Royalties, Other Intellectual Property: Patent co-inventor on 17-gene prostate assay with Genomic Health Michael Crager Employment: Exact Sciences Stock and Other Ownership Interests: Exact Sciences Travel, Accommodations, Expenses: Genomic Health Hilary Boyer Research Funding: Genomic Health (Inst) Atreya Dash Research Funding: Intuitive Surgical (Inst) Travel, Accommodations, Expenses: Intuitive Surgical Michael D. Fabrizio Stock and Other Ownership Interests: Specialty Networks, InTouch Health Consulting or Advisory Role: Dendreon, Teleflex Medical, Karl Storz, Specialty Networks, Clovis Oncology Speakers' Bureau: Astellas Pharma, Janssen, Pfizer, Merck, Bayer Travel, Accommodations, Expenses: Astellas Pharma Other Relationship: Sage Mountain Global/The Atlantic Clinic Martin E. Gleave Stock and Other Ownership Interests: OncoGenex Honoraria: Janssen, Astellas Pharma, Bayer, Sanofi, GDx, Pfizer Consulting or Advisory Role: Janssen, Astellas Pharma, Bayer, Sanofi, AstraZeneca, GDx, Pfizer Research Funding: Janssen, Astellas Pharma, Bayer Patents, Royalties, Other Intellectual Property: OncoGenex OGX-011, OGX-427, ST-CP, ST-POP Suzanne Kolb Research Funding: Genomic Health (Inst) Michael Liss Research Funding: MicrogenDx (Inst) Todd M. Morgan Consulting or Advisory Role: Myriad Genetics, TerumoBCT Research Funding: Myriad Genetics (Inst), MDxHealth (Inst), GenomeDx (Inst) Ian M. Thompson Consulting or Advisory Role: Magforce, Profound Medical Patents, Royalties, Other Intellectual Property: I have several patents with colleagues involving novel biomarkers for cancer and 2 devices for sexual dysfunction and urinary incontinence.
|
